# Development of a Fragment-Based Machine Learning Algorithm for Designing   Hybrid Drugs Optimized for Permeating Gram-Negative Bacteria

**Authors:** Rachael A. Mansbach, Inga V. Leus, Jitender Mehla, Cesar A. Lopez,, John K. Walker, Valentin V. Rybenkov, Nicolas W. Hengartner, Helen I., Zgurskaya, S. Gnanakaran

arXiv: 1907.13459 · 2019-08-01

## TL;DR

This paper introduces a novel fragment-based machine learning method, Hunting FOX, to identify chemical fragments that enhance drug permeation in Gram-negative bacteria, aiding the rational design of effective antibiotics.

## Contribution

The study presents a new topological fragment-based approach for predicting and designing compounds capable of permeating Gram-negative bacterial membranes.

## Key findings

- Identified molecular fragments linked to increased membrane permeability.
- Validated the approach with Pseudomonas aeruginosa strains.
- Demonstrated potential for generalization to other drug design tasks.

## Abstract

Gram-negative bacteria are a serious health concern due to the strong multidrug resistance that they display, partly due to the presence of a permeability barrier comprising two membranes with active efflux. New approaches are urgently needed to design antibiotics effective against these pathogens. In this work, we present a novel topological fragment-based approach ("Hunting Fragments Of X" or "Hunting FOX") to rationally "hunt for" chemical fragments that promote compound ability to permeate the outer membrane. Our approach generalizes to other drug design applications. We measure minimum inhibitory concentrations of compounds in two strains of Pseudomonas aeruginosa with variable permeability barriers and use them as an input to the Hunting FOX algorithm to identify molecular fragments responsible for enhanced outer membrane permeation properties and candidate molecules from an external library that demonstrate good permeation ability. Overall, we present proof of concept for a novel method that is expected to be valuable for rational design of hybrid drugs.

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/1907.13459/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/1907.13459/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/1907.13459/full.md

---
Source: https://tomesphere.com/paper/1907.13459